NCT06617312View on ClinicalTrials.gov

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Smoking CessationTobacco Use Disorder
Interventions
DRUG

Cytisinicline

Targets α4β2 nicotinic acetylcholine receptors

DRUG

Placebo Oral Capsule

Matched to active drug, cytisinicline

Trial Locations (1)

90049

RECRUITING

University of California Los Angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER